Oral ganciclovir in the prevention of cytomegalovirus infection in postkidney transplant 'CMV at risk' recipients: A controlled, comparative study of two regimens (750 mg Bid and 500 mg Bid)

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1383-1385

  Ahsan, N ^a   Holman, M J ^a   Sonderbye, L ^a   Langhoff, E ^a   Yang, H C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ANTIVIRAL ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GANCICLOVIR; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031831573     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00283-8     Document Type: Conference Paper

References (16)

1. Ho M: Transplant Proc 26:7, 1994
2. Metselaar HJ, Weimar W: J Antimicrob Chemother 23(suppl E):37, 1989
3. Weir MR, Irwin BC, Maters AW, et al: Transplantation 43:187, 1987
4. Bia MJ, Andiman W, Gaudio J, et al: Transplantation 40:610, 1985
5. Ahsan N, Holman MJ, Yang HC: J Am Soc Nephrol 7:1929, 1996
6. Gane E, Saliba F, Valdecasa G, et al: (presented at Annual meeting of Am Soc of Transplant Physicians and Surgeons, Dallas, TX, May 1996)
7. Spector SA, McKinle GF, Lalezari JP, et al: N Engl J Med 334:1491, 1996
8. Drew WL, Ives D, Lalezari JP, et al: N Engl J Med 333:615, 1995
9. Crumpacker CS: N Engl J Med 335:721, 1996
10. Balfour HH, Chace BA, Stapleton JT, et al: N Engl J Med 320:1381, 1989
11. Snydman DR, Werner BG, Heinze-Lacey B, et al: N Engl J Med 317:1049, 1987
12. Kletzmayr J, Kotzmann H, Popow-Kraupp T, et al: J Am Soc Nephrol 7:325, 1996
13. Anderson RD, Griffy KG, Jung D, et al: Clin Ther 17:425, 1995
14. Tocci MJ, Livelli TJ, Perry HC, et al: Antimicrob Agents Chemother 25:247, 1984
15. Drew WL, Miner R, Saleh E: Clin Diagn Virol 1:179, 1993
16. Physicians Desk Reference 1998. Montvale, NJ: Medical Economics Publishing; 1998, p 2452